Welcome to our dedicated page for AKTIS ONCOLOGY news (Ticker: AKTS), a resource for investors and traders seeking the latest updates and insights on AKTIS ONCOLOGY stock.
Aktis Oncology, Inc. reports clinical-stage oncology developments centered on targeted radiopharmaceuticals for solid tumors. The company’s miniprotein radioconjugate platform supports AKY-1189, a Nectin-4 program with potential across urothelial, breast, non-small cell lung, colorectal, cervical, and head and neck cancers, and AKY-2519, a B7-H3 program for prostate, lung, colorectal, and other solid tumors.
Recurring updates include FDA actions such as IND clearances and Fast Track designation, clinical-trial initiations, imaging and dosimetry data presentations, business and financial results, investor-conference participation, and board and committee changes. News also covers Aktis’ collaboration with Eli Lilly and Company to develop radioconjugates outside its proprietary pipeline.
Akoustis Technologies, Inc. (NASDAQ: AKTS) announced a non-brokered registered direct offering, raising approximately $21.5 million by selling 1.5 million shares at $14.36 each, set to close today. Additionally, the company secured about $14.1 million through at-the-market offerings. The total gross proceeds from both offerings amount to roughly $35.6 million. Akoustis plans a 500% capacity expansion at its New York facility to meet demand for 5G and WiFi 6E applications, further doubling its manufacturing capacity. Fifteen new filters have been added to its product catalog, targeting various wireless markets.
Akoustis Technologies has announced the development of a new wafer-level-chip-scale-packaging (WLCSP) for its XBAW® RF filters, designed for 5G mobile devices and infrastructure. This packaging solution, which aligns with the industry's demand for smaller components, will be fully manufactured in North America. The first WLCSP device is anticipated to be qualified by the end of Q1 2021, with production expected to begin in June 2021. This innovation aims to unlock new market opportunities and enhance Akoustis' position in the growing RF filter industry.
Akoustis Technologies (AKTS) reported a 30% revenue increase above guidance, driven by demand across 5G mobile, WiFi, and infrastructure markets. The company plans to double manufacturing capacity by the end of 2021 to meet expected demand. In the December quarter, revenue reached $1.308 million, though losses increased to $11.91 million. Key highlights include new customer orders for XBAW filters, achieving design-lock on WiFi 6E filters, and a growing backlog of RF products. Akoustis continues to drive strategic milestones amid market expansion.
Akoustis Technologies, Inc. (NASDAQ: AKTS) announced a volume order for its XBAW WiFi 6E RF filters from a tier-1 customer. The filters will support a new MU-MIMO router targeting the consumer market, expected to enter production in the second half of 2021. The company’s XBAW filters cover critical frequency bands from 5.1 to 7.1 GHz, facilitating robust performance in WiFi 6E applications. With increasing demand for high-performance filters, Akoustis anticipates significant revenue growth. The FCC's recent approval of new frequency bands is a pivotal development for the WiFi 6E market.
Akoustis Technologies (NASDAQ: AKTS) has announced the design-lock of its new 5.5 GHz and 6.5 GHz WiFi 6E XBAW filters, aimed at enhancing wireless connectivity. These filters, covering the UNII 1-3 and UNII 5-8 bands, promise low power loss and improved coexistence with existing frequencies. Expected to be qualified by early 2021 and in production by the end of Q2, Akoustis seeks to capitalize on the growing WiFi 6E market. The FCC's approval of additional spectrum for unlicensed use further supports this expansion. CEO Jeff Shealy emphasizes the potential for significant growth in revenue and unit sales.
Akoustis Technologies, Inc. (NASDAQ: AKTS) has announced a redemption notice for its $15 million outstanding 6.5% Convertible Senior Secured Notes due March 2021. Holders can redeem notes for 100% of principal plus accrued interest or convert to common stock at a rate of 200 shares per $1,000. CEO Jeff Shealy stated this move aims to strengthen the company’s balance sheet by eliminating convertible debt, enhancing financial stability. The details are available in a recent SEC filing, and this announcement does not constitute a securities offer.
Akoustis Technologies (AKTS) will host an investor update call on February 1, 2021, at 8:00 a.m. ET to provide a business update and outlook. The company specializes in patented bulk acoustic wave (BAW) RF filters for wireless applications and has seen increased demand for its products. In 2020, Akoustis entered production across multiple markets, including 5G infrastructure and high-band WiFi. The call will include a question-and-answer session for investors. For audio participation, dial 877-407-3982 domestically or 201-493-6780 internationally.
Akoustis Technologies, Inc. (NASDAQ: AKTS) announced participation in the 23rd Annual Needham Virtual Growth Conference on January 11, 2021. Due to Covid-19 precautions, the event will be held virtually. Investors interested in meetings with Akoustis management should contact their Needham representative or Akoustis’ investor relations at ir@akoustis.com. The company is experiencing growing demand for its XBAW® filters, having launched 15 new products targeting 5G infrastructure, high-band WiFi, and defense markets throughout 2020.
Akoustis Technologies, Inc. (NASDAQ: AKTS) announced new orders for the development of two XBAW filters for 5G mobile devices, with deliveries expected in the second half of 2021. This marks the company’s third 5G mobile device customer, highlighting growing interest in its patented XBAW filter technology. The new filters aim to enhance 5G/WiFi coexistence in mid and ultra-high bands. Akoustis is expanding its product catalog, having introduced 15 new filters in 2020, targeting various applications, including WiFi and radar systems.
Akoustis Technologies, Inc. (NASDAQ: AKTS) announced a new design win for its 5.2/5.6 GHz XBAW RF coexistence filter for a customer’s MU-MIMO Tri-Band WiFi Bridge. Production is anticipated in the second half of 2021. This marks Akoustis's third WiFi 6 design win, following a router launch in November and another customer win earlier in December. The company emphasizes its strategy to become a leading supplier of RF BAW filters for WiFi 6 and 6E applications, driven by a growing interest in its innovative high-frequency XBAW filters.